Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | NCF1 | P14598 | 2/20 | 0.46 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.42 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10798671 | 0.81 | CHEK1 (0.54) | KDM4EHSD17B10L3MBTL1KAT2BPSIP1 | |
| SCHEMBL10803538 | 0.78 | MAPT (0.69) | CYP2C19NCF1SLC2A1ALDH1A1MALT1 | |
| SCHEMBL6233644 | 0.78 | PSIP1 (0.50) | CYP2C19ALDH1A1L3MBTL1PSIP1 | |
| SCHEMBL974274 | 0.77 | NCF1 (0.53) | CYP2C19NCF1SLC2A1ALDH1A1KDM4E | |
| SCHEMBL7906171 | 0.77 | MALT1 (0.47) | CYP2C19NCF1SLC2A1ALDH1A1KDM4E | |
| SCHEMBL24711106 | 0.77 | CYP2C19 (0.47) | CYP2C19NCF1SLC2A1ALDH1A1KDM4E | |
| SCHEMBL15956333 | 0.77 | CYP2C19 (0.47) | CYP2C19NCF1SLC2A1ALDH1A1KDM4E | |
| SCHEMBL30457115 | 0.77 | NCF1 (0.53) | CYP2C19NCF1SLC2A1ALDH1A1KDM4E | |
| SCHEMBL28211899 | 0.77 | CYP2C19 (0.51) | TAAR1CYP2C19NCF1SLC2A1ALDH1A1 | |
| SCHEMBL14924462 | 0.77 | NCF1 (0.43) | NCF1SLC2A1ALDH1A1KDM4EKAT2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090163740-A1 | LIGANDS FOR METALS AS CATALYSTS FOR CARBON-CARBON BOND FORMATION | NATIONAL SUN YAT-SEN UNIVERSITY | 2009-06-25 | — | — | US | claimed |
| US-20090163740-A1 | LIGANDS FOR METALS AS CATALYSTS FOR CARBON-CARBON BOND FORMATION | NATIONAL SUN YAT-SEN UNIVERSITY | 2009-06-25 | — | — | US | disclosed |
| US-20090163740-A1 | LIGANDS FOR METALS AS CATALYSTS FOR CARBON-CARBON BOND FORMATION | NATIONAL SUN YAT-SEN UNIVERSITY | 2009-06-25 | — | — | US | disclosed |
| US-4681898-A | ANTI-DIABETIC, HYPOGLYECMIC AGENTS | SANDOZ PHARMACEUTICALS CORP. (US) | 1987-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163740-A1 | LIGANDS FOR METALS AS CATALYSTS FOR CARBON-CARBON BOND FORMATION | NCOR2, OXGR1, NCOR1 | TAAR1 46/4885CYP2C19 649/4885NCF1 2708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.